Advertisement

Topics

ESMO 2017: Cancer patients struggle with key aspects of clinical trials

22:06 EDT 9 Sep 2017 | ecancermedicalscience

Clinical trials are fundamental to the development of new treatments for cancer, yet the annual accrual to cancer clinical trials worldwide is low, estimated at three to five percent. Preliminary results of a nation-wide trial in Ireland, presented at...

Original Article: ESMO 2017: Cancer patients struggle with key aspects of clinical trials

NEXT ARTICLE

More From BioPortfolio on "ESMO 2017: Cancer patients struggle with key aspects of clinical trials"

Quick Search
Advertisement
 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...